How to recruit patients for UX research: ethical channels, screening, and incentive strategies

How to ethically recruit patients for UX and user research. Covers recruitment channels, clinician referral safeguards, condition-specific outreach, IRB-compliant screening, incentive strategies for healthcare participants, and patient panel management.

How to recruit patients for UX research: ethical channels, screening, and incentive strategies

How do you recruit patients for UX research?

Recruit patients through trusted channels (clinician referrals, patient advocacy organizations, patient portals, and health communities), screen by healthcare product usage and care stage rather than diagnosis, obtain informed consent that meets IRB and HIPAA requirements, and compensate immediately regardless of session completion. The critical difference from standard recruitment: patients are potentially vulnerable, healthcare relationships create power dynamics that can feel coercive, and regulatory requirements (IRB, HIPAA) add compliance layers that must be addressed before the first outreach message is sent.

How do you avoid coercion when recruiting patients?

Coercion in patient recruitment occurs when the power dynamic between the recruiter and the patient makes participation feel obligatory rather than voluntary. The most common source: clinician referrals where the patient fears that declining will affect their care. Prevent coercion by: separating the recruitment process from the care relationship (the clinician mentions the opportunity, a separate researcher handles enrollment), never making the clinician’s recommendation feel like a medical instruction, stating clearly that participation has no effect on care, and ensuring the incentive is fair compensation for time, not an inducement that exploits financial vulnerability.

Do you need IRB approval to recruit patients for UX research?

If you recruit based on a health condition, the research involves clinical populations, or findings will support a regulatory submission, IRB review is strongly recommended and often required. If you recruit based on product usage (“people who use a patient portal”) without targeting a specific condition, and use only synthetic data, IRB may not be formally required. When in doubt, submit for IRB review. The cost (4-8 weeks, $1,000-3,000 for commercial IRB) is far less than the risk of conducting non-compliant research with patients. See our pharma compliance guide for detailed IRB requirements.

What incentive should you pay patient research participants?

$75-125 for a 30-minute session, $100-150 for 60 minutes, $150-300 for a 2-4 week diary study. Pay immediately and unconditionally. Never tie payment to session completion because doing so is coercive for participants who may need to stop due to fatigue, pain, or emotional distress. Offer payment method choice: some patients prefer gift cards, others prefer direct payment, and some prefer a donation to a health charity in their name. For patients with financial vulnerability, ensure the incentive does not affect benefits eligibility (some government programs have income thresholds).

How do you screen patients without stigmatizing them?

Screen by behavior and product usage, not by diagnosis. “Do you use a patient portal or health app?” not “Do you have diabetes?” If condition-specific research is necessary, use inclusive language: “Are you currently managing an ongoing health condition?” rather than “Do you suffer from [condition]?” For emotional wellbeing screening, embed PHQ-2/GAD-2 within a broader screener (not labeled as “mental health assessment”) and route participants above clinical thresholds to compassionate exclusion with resource provision.

Can you recruit through clinicians without creating a power imbalance?

Yes, but with specific safeguards. The clinician introduces the research opportunity (hands a flyer, mentions during a visit) but does not enroll patients. A separate researcher, who has no care relationship with the patient, handles screening, consent, and enrollment. The clinician never knows which patients chose to participate. The consent form states explicitly: “Your healthcare will not be affected whether you participate or not.” And the clinician does not receive individual participant data or feedback.

Key takeaways

  • Recruit by healthcare product usage and care stage, not by diagnosis. This is more ethical, broader in reach, and often avoids the need for IRB review
  • Every recruitment channel for patients has a power dynamic to manage. Clinician referrals require separation of care and research. Portal recruitment must not feel like a system requirement. Community outreach must respect the purpose of support spaces
  • Pay immediately, unconditionally, and at a rate that respects the participant’s time without exploiting financial vulnerability
  • Screen behaviorally, not diagnostically. Embed wellbeing screeners naturally and route vulnerable participants to compassionate exclusion with resources
  • Plan 8-12 weeks for patient recruitment (longer than standard B2B) because IRB approval, channel partnerships, and ethical screening add time

Recruitment channels for patient participants

Channel 1: Clinician referrals

Clinician referrals produce the highest-quality patient participants because clinicians can identify patients who match your research criteria and who are stable enough to participate.

How it works:

  1. Provide clinicians with IRB-approved recruitment materials (flyer, brief description)
  2. The clinician mentions the opportunity during a routine visit: “There’s a research study about improving the [product]. Here’s information if you’re interested”
  3. Interested patients contact the research team directly (phone number or email on the flyer)
  4. The research team handles all screening, consent, and enrollment independently

Safeguards:

  • The clinician never pressures or recommends participation
  • The clinician does not know who participates or what they share
  • The consent form states participation does not affect care
  • Recruitment materials are reviewed and approved by IRB before use

Yield: 10-20% of patients who receive a flyer express interest. Of those, 60-80% meet screening criteria and consent. Plan for 50-100 flyers distributed per 10 enrolled participants.

Channel 2: Patient portals and EHR systems

Patient portals (MyChart, Epic, Cerner) can display recruitment banners to logged-in patients who match study criteria.

How it works:

  • Work with the health system’s IT and research teams to display a recruitment banner to patients matching your criteria (condition, age, portal usage frequency)
  • The banner links to a screening questionnaire hosted on a HIPAA-compliant platform
  • Patients who complete screening and meet criteria are contacted by the research team

Advantages:

  • Reaches patients who are already digitally engaged (they use the portal)
  • Targeting can be precise (condition, demographics, treatment stage) without the researcher accessing PHI directly
  • Self-selection: patients choose to click, reducing coercion risk

Challenges:

  • Requires partnership with the health system (IT, legal, IRB, clinical leadership)
  • Setup takes 4-8 weeks for banner approval and technical implementation
  • Reaches only patients who use the portal (excludes low digital literacy populations)

Channel 3: Patient advocacy organizations

Disease-specific organizations (American Diabetes Association, American Heart Association, NAMI, Crohn’s & Colitis Foundation, etc.) have direct relationships with engaged patients.

How it works:

  • Partner with the organization’s research or programs team
  • Provide recruitment materials for their newsletter, website, social channels, or support groups
  • The organization distributes; interested patients contact you directly

Advantages:

  • Patients trust the organization, which transfers trust to your research
  • Reaches patients across the condition spectrum (newly diagnosed to long-term management)
  • No direct PHI exchange between you and the organization

Best practices:

  • Offer to share anonymized research findings with the organization
  • Respect the organization’s mission: your research should align with their goals
  • Never recruit directly from support group meetings without the organization’s explicit approval and participant consent

Channel 4: Online patient communities

CommunityBest forApproach
Reddit health subreddits (r/diabetes, r/CrohnsDisease, r/ChronicPain, etc.)Condition-specific patients, active digital usersPost in subreddits that allow research recruitment (check rules). Transparent, non-clinical framing
HealthUnlockedUK and international patients across conditionsPartner with community moderators for approved recruitment
PatientsLikeMePatients sharing health data, quantified-self orientedPost in research sections, emphasize data privacy
InspireCondition-specific support communitiesPartner with Inspire for compliant recruitment through their platform
Facebook health groupsBroad reach, condition-specific groupsPost with group admin approval only. Be transparent about who you are and why

Ethical guardrails for community recruitment:

  • Never send unsolicited DMs to people who post about their health conditions
  • Always disclose who you are, who funds the research, and how data will be used
  • Respect community rules. If a community prohibits research recruitment, do not recruit there
  • Do not recruit from active crisis support threads or channels

Channel 5: Verified B2B research panels

CleverX verified panels and similar platforms can source pre-screened healthcare participants:

  • Healthcare professionals (clinicians, nurses, pharmacists) for provider-perspective research
  • Patient panels filtered by demographics, condition category, and digital tool usage
  • Role verification reduces fraud risk that self-reported condition-based recruitment faces

Channel 6: Your own product user base

If you have a live healthcare product (patient portal, health app, telehealth platform), in-product recruitment reaches users with real context.

Best practices:

  • Show recruitment banners after meaningful usage (not on first login)
  • Frame as improvement: “Help us make [product] better for patients like you”
  • Do not require participation for continued product access (coercive)
  • Ensure the recruitment process does not access the user’s health data without consent

Channel comparison

ChannelReachTrust levelSetup timeCoercion riskBest for
Clinician referralTargetedVery high4-8 weeks (IRB)Medium (manage actively)Condition-specific research
Patient portalBroad, digital usersHigh4-8 weeks (IT + IRB)Low (self-selection)Portal/digital health research
Advocacy orgsCondition-specificHigh2-4 weeksLowCondition journey research
Online communitiesBroad, digitally activeMedium1-2 weeksLowBroad patient experience research
Research panelsBroad, pre-screenedMedium1 weekLowQuick recruitment, multi-condition
Own user baseProduct usersHighMinimalLow-mediumProduct-specific research

How to screen patient participants

Behavioral screening (not diagnostic)

Screener structure (6-8 questions, under 3 minutes):

Section 1: Relevance

  1. Do you currently use any of the following? (Multi-select: patient portal, health app, telehealth, prescription management app, health wearable, none. Primary filter)
  2. How often do you interact with the healthcare system? (Daily / Weekly / Monthly / Quarterly / Rarely. Indicates care intensity)
  3. How would you describe your comfort level discussing your healthcare experiences? (Very comfortable / Somewhat comfortable / Prefer to keep details private / Not comfortable. Route accordingly)

Section 2: Context (non-diagnostic)

  1. Are you currently managing an ongoing health condition? (Yes / No. Do not ask which condition unless essential for your study)
  2. How long have you been managing this condition? (Under 6 months / 6 months - 2 years / 2-5 years / 5+ years. Segments by care stage)
  3. How confident are you using technology for health management? (Very / Somewhat / Not very / Not at all. Ensures digital literacy diversity)

Section 3: Wellbeing (if study involves sensitive topics)

  1. Over the past two weeks, how often have you been bothered by feeling down, depressed, or hopeless? (PHQ-2 item. Not at all / Several days / More than half the days / Nearly every day)
  2. Over the past two weeks, how often have you been bothered by feeling nervous, anxious, or on edge? (GAD-2 item)

Scoring and routing:

Combined PHQ-2 + GAD-2 scoreAction
0-4Include. Standard protocol
5-8Include with enhanced protocol: additional check-ins, trauma-informed facilitation
9-12Exclude with compassionate messaging and resource provision

Condition-specific screening (when needed)

When your study requires participants with a specific condition, screen with sensitivity:

  • Use inclusive framing: “This study is for people who manage [condition] as part of their daily life” rather than “Do you have [condition]?”
  • Do not ask for diagnosis verification or medical records in the screener
  • If clinical verification is essential, partner with a clinical site where clinicians confirm eligibility (the researcher never sees medical records)
  • Allow self-identification: if a participant says they manage the condition, accept their self-report unless clinical verification is required by your IRB protocol

Patient-specific incentive strategies

The unconditional payment principle

State in every recruitment message, consent form, and session script: “You will receive your full payment regardless of whether you complete all tasks or choose to end early.” This is not just good practice. For patient populations, conditional payment is coercive because:

  • Patients may push through pain or fatigue to earn the incentive
  • Patients in financial difficulty may participate when they should not
  • The power dynamic between “researcher with money” and “patient who needs money” must not influence participation decisions

Incentive benchmarks by study type

Study typeRatePayment timingNotes
30-min interview$75-125Same dayHigher end for condition-specific studies
60-min usability test$100-150Same dayInclude break time. Do not penalize for fatigue breaks
2-week diary study$150-250 totalPartial at day 7, remainder at day 14Pay day 7 amount even if they withdraw early
4-week diary study$250-400 totalPayments at day 7, 14, 21, 28Each payment unconditional
Co-design workshop (2 hours)$100-200Same dayAcknowledge their expertise explicitly
Caregiver interview (30 min)$75-150Same dayOften overlooked but critical
Healthcare professional evaluation$150-300/hrSame dayStandard B2B healthcare rate

Alternative and supplementary incentives

Some patients respond to value-aligned incentives alongside or instead of cash:

Donation in their name. Offer to donate to a health charity (condition-specific foundation, patient advocacy org) in the participant’s name. Effective for patients who feel strongly about their condition’s community.

Health product credits. Credits for health apps, wellness subscriptions, or pharmacy gift cards. Practical and relevant.

Results sharing. “We will share what we learned from this research with you.” Patients who participate because they want to improve healthcare for others value seeing the impact of their contribution.

Do not assume. Always offer cash as the primary option. Value-aligned alternatives are supplements, not replacements. Assuming a patient wants a charity donation because they have a condition is presumptuous.

Benefits eligibility consideration

Some patients receive government benefits (Medicaid, SSI, SSDI) with income thresholds. A $150 research incentive could theoretically affect benefits eligibility if it pushes monthly income above the threshold. While research incentives are generally not counted as earned income, the rules are complex. For studies with financially vulnerable populations, consult with a benefits advisor or inform participants: “Research incentives are generally not considered earned income, but if you have concerns about how this payment might affect your benefits, we recommend checking with your case manager.”

How to manage a patient research panel

Patient panel vs. standard B2B panel

DimensionStandard B2B panelPatient panel
Contact frequencyMonthly outreach acceptableQuarterly maximum. Patients fatigue faster
Wellbeing monitoringNot neededRe-screen with PHQ-2/GAD-2 before each study
Data sensitivityStandard PIIHealth-related PII. HIPAA-equivalent protections even if HIPAA does not formally apply
Condition changesN/APatients’ conditions change. Re-verify relevance before each study
Emotional burden trackingNot neededMonitor for cumulative research fatigue, especially for chronic condition patients
Consent refreshAnnualPer-study (each study may involve different topics and data handling)

Panel maintenance

  • Re-screen before every study. A patient who was stable 3 months ago may not be now. Re-administer PHQ-2/GAD-2 for studies involving sensitive topics
  • Cap at one study per quarter. Patient participants have less bandwidth than professional participants. Respect their time and energy
  • Track condition trajectory. Patients’ conditions change. Someone managing early-stage diabetes 6 months ago may now be on insulin. Update their profile before re-engaging
  • Provide ongoing value. Share (anonymized) research findings with panelists. “Here’s what we learned from your participation and how it’s changing the product” maintains engagement and demonstrates impact
  • Easy permanent opt-out. A clear, one-click process for patients to remove themselves permanently. No guilt, no “are you sure?” prompts

Frequently asked questions

How long does it take to recruit patient participants?

4-8 weeks for condition-specific research through clinical referrals or advocacy organizations. 2-4 weeks for product-usage-based recruitment through portals or online communities. 1-2 weeks through verified research panels. Add 4-8 weeks for IRB approval if required. Total timeline for a compliant condition-specific study: 8-16 weeks from planning to first session.

Can you recruit patients for remote research?

Yes, and for many patients remote is preferred. Remote participation avoids travel burden (important for patients with mobility limitations, pain, or fatigue), allows participation from home (the environment where most health management happens), and broadens geographic diversity. Offer multiple remote formats: video call (for those with webcam and stable internet), phone call (for those with limited internet), and asynchronous (for those who cannot commit to a scheduled time). Always offer cameras-off as the default.

How do you recruit patients with rare conditions?

Partner with condition-specific advocacy organizations (they often have the most concentrated access to rare condition communities), post in rare disease communities (NORD, Global Genes, condition-specific Facebook groups and forums), use verified panels with condition filters, and accept that recruitment will take longer (6-12 weeks). For very rare conditions (fewer than 200,000 patients in the US), 3-5 participants may be the maximum achievable sample. Supplement with caregiver interviews and clinician evaluator sessions to expand your data.

How do you handle patients who want to share more than the study requires?

Patients sometimes use research sessions as an opportunity to share their full health story, including details beyond the study scope. Listen respectfully. Do not cut them off. The extra information may provide valuable context even if it is not part of your task protocol. If the sharing becomes distressing for the participant, apply trauma-informed principles: pause, acknowledge, offer a break. If the participant shares information that suggests they need medical attention (“I’ve been having chest pain for a week and haven’t told my doctor”), encourage them to contact their provider and provide relevant resources.

Should you include caregivers in patient recruitment?

Yes, as a separate participant segment. Caregivers are often the primary users of patient-facing health technology (they manage portals, schedule appointments, track medications, communicate with providers on behalf of the patient). Recruit caregivers through the same channels as patients, but with separate screening and consent. Caregiver insights complement patient perspectives and reveal the “invisible user” layer that patient-only research misses.

How do you recruit patients who are not digitally engaged?

Offline channels: clinic waiting room flyers (IRB-approved), community health center bulletin boards, pharmacy partnerships, faith-based organization health ministries, senior center outreach, and public library health program partnerships. For these participants, offer phone-based sessions (not video), paper consent forms (mailed and returned), and payment via physical gift card or check (not digital transfer). Digital exclusion is a real bias in patient research. Actively recruiting non-digital patients ensures your product works for the full patient population, not just tech-savvy patients.